{"id":140002,"date":"2018-04-09T10:14:38","date_gmt":"2018-04-09T10:14:38","guid":{"rendered":"https:\/\/stg.strategist1trial.com\/the-strategist3-trial\/"},"modified":"2025-10-06T16:19:19","modified_gmt":"2025-10-06T16:19:19","slug":"the-strategist3-trial","status":"publish","type":"page","link":"https:\/\/stg.strategist3trial.com\/en-au\/","title":{"rendered":"The StrateGIST3 Trial"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112255&#8243; back_repeat=&#8221;no-repeat&#8221; back_attachment=&#8221;scroll&#8221; back_position=&#8221;center center&#8221; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_flip=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-681992&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; el_class=&#8221;gradient&#8221; uncode_shortcode_id=&#8221;821871&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_bottom_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;iphone&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;bottom&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; expand_height=&#8221;yes&#8221; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;7&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;200&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;177675&#8243; column_width_pixel=&#8221;1000&#8243;][vc_empty_space empty_h=&#8221;5&#8243;][vc_single_image media=&#8221;138416&#8243; media_width_percent=&#8221;36&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;624267&#8243;][vc_column_text text_color=&#8221;color-jevc&#8221; uncode_shortcode_id=&#8221;137548&#8243; text_color_type=&#8221;uncode-palette&#8221;]IDRX-42 (GSK6042981) is a highly selective and powerful inhibitor of the KIT protein, which is overactive in many people with GIST, causing the cancer cells to grow and accumulate.[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112267&#8243; back_repeat=&#8221;no-repeat&#8221; back_attachment=&#8221;fixed&#8221; back_position=&#8221;center top&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-681992&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; row_name=&#8221;iphone&#8221; el_class=&#8221;gradient&#8221; uncode_shortcode_id=&#8221;159258&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_bottom_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;7&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;200&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;276875&#8243; column_width_pixel=&#8221;1000&#8243;][vc_empty_space empty_h=&#8221;1&#8243;][vc_single_image media=&#8221;138416&#8243; media_width_percent=&#8221;45&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;927066&#8243;][vc_empty_space empty_h=&#8221;1&#8243;][vc_button button_color=&#8221;color-681992&#8243; border_width=&#8221;0&#8243; uncode_shortcode_id=&#8221;321186&#8243; width=&#8221;216&#8243; link=&#8221;url:%23study-description|title:FAQs|&#8221; button_color_type=&#8221;uncode-palette&#8221;]Learn more[\/vc_button][vc_empty_space empty_h=&#8221;2&#8243;][vc_column_text text_color=&#8221;color-196438&#8243; uncode_shortcode_id=&#8221;111155&#8243; text_color_type=&#8221;uncode-palette&#8221;]Click here to watch a video about StrateGIST 3, including the purpose of the study, who can join the study, the study drugs, and what to expect during the study.[\/vc_column_text][vc_single_image media=&#8221;123015&#8243; media_width_percent=&#8221;100&#8243; uncode_shortcode_id=&#8221;157773&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112266&#8243; back_attachment=&#8221;scroll&#8221; back_position=&#8221;center bottom&#8221; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-681992&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; row_name=&#8221;iphone&#8221; el_class=&#8221;gradient&#8221; uncode_shortcode_id=&#8221;204395&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_bottom_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;7&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;200&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;276875&#8243; column_width_pixel=&#8221;1000&#8243;][vc_empty_space empty_h=&#8221;1&#8243;][vc_single_image media=&#8221;138416&#8243; media_width_percent=&#8221;60&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;482822&#8243;][vc_button button_color=&#8221;color-681992&#8243; border_width=&#8221;0&#8243; uncode_shortcode_id=&#8221;155178&#8243; width=&#8221;216&#8243; link=&#8221;url:%23study-description|title:FAQs|&#8221; button_color_type=&#8221;uncode-palette&#8221;]Learn more[\/vc_button][vc_empty_space empty_h=&#8221;0&#8243;][vc_column_text text_color=&#8221;color-196438&#8243; uncode_shortcode_id=&#8221;111155&#8243; text_color_type=&#8221;uncode-palette&#8221;]Click here to watch a video about StrateGIST 3, including the purpose of the study, who can join the study, the study drugs, and what to expect during the study.[\/vc_column_text][vc_empty_space empty_h=&#8221;0&#8243;][vc_single_image media=&#8221;123015&#8243; media_width_percent=&#8221;100&#8243; uncode_shortcode_id=&#8221;157773&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;50&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;4&#8243; bottom_padding=&#8221;3&#8243; back_color=&#8221;color-681992&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; bottom_divider=&#8221;tilt&#8221; uncode_shortcode_id=&#8221;168548&#8243; back_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;study-description&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; column_width_pixel=&#8221;1000&#8243; uncode_shortcode_id=&#8221;145453&#8243;][vc_custom_heading text_color=&#8221;color-138503&#8243; heading_semantic=&#8221;h1&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; uncode_shortcode_id=&#8221;671518&#8243; text_color_type=&#8221;uncode-palette&#8221;]<strong>What is StrateGIST 3?<\/strong>[\/vc_custom_heading][vc_column_text text_color=&#8221;color-xsdn&#8221; uncode_shortcode_id=&#8221;775611&#8243; text_color_type=&#8221;uncode-palette&#8221;]<span style=\"font-weight: 400;\"><strong style=\"font-size: 20px; color: #ffffff;\">StrateGIST 3<\/strong> is a clinical trial testing an investigational drug (study drug) called IDRX-42 (GSK6042981) in adults with metastatic and\/or unresectable gastrointestinal stromal tumours (GIST) who have progressed on or were intolerant to first-line therapy with imatinib.<\/span> <span style=\"font-weight: 400;\">Researchers want to learn more about the safety IDRX-42 (GSK6042981) and compare its effects with sunitinib, which is a treatment approved in some countries for the type of GIST being studied.<\/span> <span style=\"font-weight: 400;\">This trial will build upon learnings about IDRX-42 (GSK6042981) from an&nbsp;earlier trial in people living with GIST.<\/span>[\/vc_column_text][vc_column_text text_color=&#8221;color-xsdn&#8221; uncode_shortcode_id=&#8221;246950&#8243; text_color_type=&#8221;uncode-palette&#8221;]The video below provides an overview of StrateGIST 3, including the purpose of the study, who can join the study, the study drugs, and what to expect during the study.[\/vc_column_text][vc_empty_space empty_h=&#8221;3&#8243;][vc_button button_color=&#8221;color-196438&#8243; border_animation=&#8221;btn-ripple-out&#8221; border_width=&#8221;0&#8243; display=&#8221;inline&#8221; link=&#8221;url:%23location|title:Join%20the%20Study|&#8221; button_color_type=&#8221;uncode-palette&#8221; width=&#8221;216&#8243; uncode_shortcode_id=&#8221;132884&#8243;]Find a clinical trial site[\/vc_button][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;7&#8243; bottom_padding=&#8221;7&#8243; back_color=&#8221;color-138503&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_top_divider=&#8221;default&#8221; top_divider=&#8221;tilt&#8221; shape_top_h_use_pixel=&#8221;&#8221; shape_top_height=&#8221;100&#8243; shape_top_color=&#8221;color-681992&#8243; shape_top_opacity=&#8221;100&#8243; shape_top_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider=&#8221;tilt&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;150&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; uncode_shortcode_id=&#8221;152579&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_top_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; sticky=&#8221;yes&#8221; width=&#8221;1\/2&#8243; uncode_shortcode_id=&#8221;179542&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;right&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;242247&#8243;][vc_custom_heading text_size=&#8221;&#8221; uncode_shortcode_id=&#8221;506177&#8243;]<strong>What happens during the trial?<\/strong>[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_column_text uncode_shortcode_id=&#8221;183718&#8243;]<span style=\"font-weight: 400\">The trial will test the study drug, IDRX-42, in adults who have metastatic and\/or unresectable GIST that has progressed while taking imatinib or who do not tolerate imatinib side effects. The goal is to compare the effects of IDRX-42 versus sunitinib.<\/span><\/p>\n<p><span style=\"font-weight: 400\">IDRX-42 is a study drug and has not been approved by any healthcare authority for use outside of a clinical trial.<\/span>[\/vc_column_text][vc_empty_space empty_h=&#8221;4&#8243;][\/vc_column][vc_column column_width_percent=&#8221;95&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; css_animation=&#8221;alpha-anim&#8221; width=&#8221;1\/2&#8243; uncode_shortcode_id=&#8221;900895&#8243;][vc_custom_heading text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;954054&#8243;]Informed Consent[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;195636&#8243;]<span style=\"font-weight: 400\">Before you decide whether you want to participate, the study team will review the details of the trial with you. This includes possible risks and benefits and what you can expect if you joined. If you decide to participate, you will be asked to sign an Informed Consent Form. This confirms that you understand the trial and are willing to take part to determine if you are eligible.<\/span>[\/vc_column_text][vc_separator sep_color=&#8221;color-prif&#8221; uncode_shortcode_id=&#8221;169390&#8243; sep_color_type=&#8221;uncode-palette&#8221;][vc_custom_heading text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;178847&#8243;]<span class='tooltipsall tooltip_post_id_112286 classtoolTips112286'>Screening<\/span>[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;350149&#8243;]<span style=\"font-weight: 400\">To see if you qualify, you will have at least 1 visit to the study site to answer questions about your health and the medicines you take, and to have some tests.<\/span>[\/vc_column_text][vc_separator sep_color=&#8221;color-prif&#8221; uncode_shortcode_id=&#8221;169390&#8243; sep_color_type=&#8221;uncode-palette&#8221;][vc_custom_heading text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;209503&#8243;]Trial Treatment[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;132873&#8243;]<span style=\"font-weight: 400\">If you qualify for the trial, you will be placed by chance into a group to receive either IDRX-42 or sunitinib (the approved treatment).&nbsp;<\/span><\/p>\n<p><span style=\"font-weight: 400\">IDRX-42 is provided as tablets that are taken by mouth once a day at home. IDRX-42 is taken every day. Sunitinib is taken for 28 days in a row, followed by a 14-day break (unless otherwise instructed by your doctor).&nbsp;<\/span><\/p>\n<p><span style=\"font-weight: 400\">During the <span class='tooltipsall tooltip_post_id_112287 classtoolTips112287'>Study Treatment<\/span> Period, you will come to the study site to check on your health and how your cancer is responding to the study treatment (IDRX-42 or sunitinib).<\/span><\/p>\n<p><span style=\"font-weight: 400\">If you are taking sunitinib and your cancer worsens, you may be able to switch to IDRX-42.<\/span><\/p>\n<p><strong>The study treatment (IDRX-42 or sunitinib), visits, and study-related tests will be paid for by the clinical trial sponsor. Reimbursement will be available for study visit-related travel expenses.<\/strong>[\/vc_column_text][vc_separator sep_color=&#8221;color-prif&#8221; uncode_shortcode_id=&#8221;447472&#8243; sep_color_type=&#8221;uncode-palette&#8221;][vc_custom_heading text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;165143&#8243;]<span class='tooltipsall tooltip_post_id_112288 classtoolTips112288'>Follow-up<\/span>[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;435261&#8243;]<span style=\"font-weight: 400\">Once you and your doctor decide to stop the study treatment, you will have 2 more visits and will have phone calls with the study team every 3 months.<\/span>[\/vc_column_text][vc_empty_space empty_h=&#8221;2&#8243;][vc_button button_color=&#8221;color-681992&#8243; border_animation=&#8221;btn-ripple-out&#8221; border_width=&#8221;0&#8243; uncode_shortcode_id=&#8221;626023&#8243; link=&#8221;url:https%3A%2F%2Fstg.strategist1trial.com%2Ffaqs-2%2F|title:FAQs|&#8221; button_color_type=&#8221;uncode-palette&#8221;]Explore StrateGIST 3 FAQs[\/vc_button][vc_empty_space empty_h=&#8221;2&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; back_color=&#8221;color-138503&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_top_divider=&#8221;default&#8221; top_divider=&#8221;tilt&#8221; shape_top_h_use_pixel=&#8221;&#8221; shape_top_height=&#8221;100&#8243; shape_top_color=&#8221;color-681992&#8243; shape_top_opacity=&#8221;100&#8243; shape_top_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider=&#8221;tilt&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;150&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;944839&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_top_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; sticky=&#8221;yes&#8221; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;580905&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;right&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;111259&#8243;][vc_empty_space empty_h=&#8221;3&#8243;][vc_custom_heading text_size=&#8221;&#8221; uncode_shortcode_id=&#8221;506177&#8243;]<strong>What happens during the trial?<\/strong>[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;105390&#8243;]<span style=\"font-weight: 400;\">The trial will test the study drug, IDRX-42 (GSK6042981), in adults who have metastatic and\/or unresectable GIST that has progressed while taking imatinib or who do not tolerate imatinib side effects. The goal is to compare the safety and effects of IDRX-42 (GSK6042981) versus sunitinib.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">IDRX-42 (GSK6042981) is a study drug and has not been approved by any healthcare authority for use outside of a clinical trial.<\/span>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;158094&#8243;][vc_custom_heading uncode_shortcode_id=&#8221;175823&#8243;]Your StrateGIST 3 Journey[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; limit_content=&#8221;&#8221; uncode_shortcode_id=&#8221;663441&#8243;][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;158744&#8243;][vc_single_image media=&#8221;140011&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;145159&#8243;][vc_single_image media=&#8221;140034&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;438492&#8243;][vc_single_image media=&#8221;140057&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;121660&#8243;][vc_single_image media=&#8221;140080&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;508277&#8243;][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; limit_content=&#8221;&#8221; uncode_shortcode_id=&#8221;143909&#8243;][vc_column_inner width=&#8221;1\/1&#8243;][vc_single_image media=&#8221;138536&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;165287&#8243;][vc_single_image media=&#8221;138476&#8243; media_width_percent=&#8221;11&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;197707&#8243;][vc_single_image media=&#8221;138516&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;840834&#8243;][vc_single_image media=&#8221;138476&#8243; media_width_percent=&#8221;11&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;746250&#8243;][vc_single_image media=&#8221;112312&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;108810&#8243;][vc_single_image media=&#8221;138476&#8243; media_width_percent=&#8221;11&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;121070&#8243;][vc_single_image media=&#8221;138496&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;868346&#8243;][\/vc_column_inner][\/vc_row_inner][vc_empty_space empty_h=&#8221;3&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;888870&#8243;][vc_button border_width=&#8221;0&#8243; link=&#8221;url:https%3A%2F%2Fstg.strategist1trial.com%2Ffaqs-2%2F|title:FAQs|&#8221; uncode_shortcode_id=&#8221;185672&#8243;]FAQs[\/vc_button][vc_empty_space empty_h=&#8221;3&#8243;][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; back_image=&#8221;111788&#8243; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_top_divider=&#8221;default&#8221; top_divider=&#8221;tilt&#8221; shape_top_h_use_pixel=&#8221;&#8221; shape_top_height=&#8221;100&#8243; shape_top_opacity=&#8221;100&#8243; shape_top_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider=&#8221;tilt&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; uncode_shortcode_id=&#8221;155709&#8243; back_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;locations&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;881793&#8243; column_width_pixel=&#8221;900&#8243;][vc_empty_space][vc_custom_heading text_size=&#8221;&#8221; uncode_shortcode_id=&#8221;176181&#8243;]<span style=\"font-weight: 400\">Interested in learning more? <\/span>[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;183639&#8243;]<span style=\"font-weight: 400\">Talk to your doctor for more information and click on the link below to find a StrateGIST 1 Trial site near you.<\/span>[\/vc_column_text][vc_column_text uncode_shortcode_id=&#8221;654154&#8243;]<b>Participation in the trial is voluntary and you can choose to leave at any time.<\/b>[\/vc_column_text][vc_empty_space empty_h=&#8221;2&#8243;][vc_button button_color=&#8221;color-773321&#8243; border_animation=&#8221;btn-ripple-out&#8221; border_width=&#8221;0&#8243; uncode_shortcode_id=&#8221;214268&#8243; link=&#8221;url:https%3A%2F%2Fstg.strategisttrials.com%2Ffaqs%2F|title:FAQs|&#8221; button_color_type=&#8221;uncode-palette&#8221;]Find a clinical trial site[\/vc_button][vc_empty_space empty_h=&#8221;5&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;936538&#8243; back_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;location&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;881793&#8243; column_width_pixel=&#8221;900&#8243;][vc_custom_heading text_size=&#8221;&#8221; uncode_shortcode_id=&#8221;118699&#8243;]Interested in learning more?[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;135948&#8243;]<span style=\"font-weight: 400;\">Talk to your doctor for more information about StrateGIST 3.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">You may also click on a location on the map below to find a StrateGIST 3 site near you. StrateGIST 3 will be available in up to 150 clinical trial sites globally. New sites may be opening, so please check back for updates.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Study visit-related travel expenses may be reimbursed.<\/span>[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;2&#8243; bottom_padding=&#8221;5&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;150898&#8243; back_color_type=&#8221;uncode-palette&#8221;][vc_column width=&#8221;1\/1&#8243;][vc_column_text uncode_shortcode_id=&#8221;326645&#8243;]                <script>\r\n                    const mapStyle = [];\r\n                    const marker_icon = '';\r\n                <\/script>\r\n\t\t\t            <div class=\"store-info-container \">\r\n                <div class=\"store-locations\">\r\n                    <div class=\"store-locations-search OneLinkTx\">\r\n                        <form role=\"search\" class=\"store-search-form\">\r\n                            <label for=\"search-text\"><\/label>\r\n                            <input type=\"text\" value name=\"search-text\" id=\"search-text\"\r\n                                   placeholder=\"Enter a location\">\r\n                            <input type=\"image\" id=\"search-btn\" alt=\"Search\" src=\"https:\/\/stg.strategist3trial.com\/wp-content\/plugins\/jh-wp-site-listing-main\/images\/icon-arrow-right.svg\">\r\n                            <input type=\"hidden\" id=\"place_lat\" value=\"\">\r\n                            <input type=\"hidden\" id=\"place_lng\" value=\"\">\r\n                            <input type=\"hidden\" id=\"show_map\" name=\"show_map\"\r\n                                   value=\"yes\">\r\n\t\t\t\t\t\t\t                            <input type=\"hidden\" id=\"language_code\" value=\"en-au\">\r\n                        <\/form>\r\n\t\t\t\t\t\t                            <div class=\"my-location\">\r\n                                <a href=\"javascript:void(0);\" onClick=\"getuser_location();\">\r\n\t\t\t\t\t\t\t\t\tUse my Location                                <\/a>\r\n                            <\/div>\r\n\t\t\t\t\t\t                    <\/div>\r\n                    <h5 class=\"store-locations-result-info OneLinkTx\">\r\n\t\t\t\t\t\tShowing                        <span id=\"found-results\"> 0<\/span> Results Near You                    <\/h5>\r\n\t\t\t\t\t                    <div class=\"store-locations-list\" id=\"ajax_results_wrapper\">\r\n                    <\/div>\r\n                <\/div>\r\n\t\t\t\t                    <div class=\"store-map-wrapper\">\r\n                        <div id=\"store-map\">\r\n                        <\/div>\r\n                    <\/div>\r\n\t\t\t\t            <\/div>\r\n\t\t\t[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; uncode_shortcode_id=&#8221;107948&#8243;][vc_column width=&#8221;1\/1&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/4&#8243; uncode_shortcode_id=&#8221;136670&#8243;][vc_raw_html]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[\/vc_raw_html][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;961362&#8243; subheading=&#8221;(learn about the trial and agree to take part)&#8221;]Informed Consent[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/4&#8243; uncode_shortcode_id=&#8221;443498&#8243;][vc_raw_html]W3Rvb2x0aXBzIGtleXdvcmQgPSAiPGltZyBzcmM9Imh0dHBzOi8vc3RnLnN0cmF0ZWdpc3QxdHJpYWwuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDI0LzExL2hlYWx0aC1zdGF0dXMucG5nIi8+IiBjb250ZW50ID0gIjxoMz5TY3JlZW5pbmc8L2gzPjxkaXY+PGg2PlRvIHNlZSBpZiB5b3UgcXVhbGlmeSwgeW91IHdpbGwgaGF2ZSBhdCBsZWFzdCAxIHZpc2l0IHRvIHRoZSBzdHVkeSBzaXRlIHRvIGFuc3dlciBxdWVzdGlvbnMgYWJvdXQgeW91ciBoZWFsdGggYW5kIHRoZSBtZWRpY2luZXMgeW91IHRha2UsIGFuZCB0byBoYXZlIHNvbWUgdGVzdHMuPC9oNj48YnI+PGJyPjwvZGl2PiJd[\/vc_raw_html][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;927570&#8243; subheading=&#8221;(see if you qualify)&#8221;]<span class='tooltipsall tooltip_post_id_112286 classtoolTips112286'>Screening<\/span>[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/4&#8243; uncode_shortcode_id=&#8221;755785&#8243;][vc_raw_html]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[\/vc_raw_html][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;665102&#8243; subheading=&#8221;IDRX-42 or sunitinib&#8221;]Trial Treatment[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/4&#8243; uncode_shortcode_id=&#8221;127480&#8243;][vc_raw_html]W3Rvb2x0aXBzIGtleXdvcmQgPSAiPGltZyBzcmM9Imh0dHBzOi8vc3RnLnN0cmF0ZWdpc3QxdHJpYWwuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDI0LzExL0FnZS5wbmciLz4iIGNvbnRlbnQgPSAiPGgyPkZvbGxvdy11cDwvaDI+PGRpdj48aDY+T25jZSB5b3UgYW5kIHlvdXIgZG9jdG9yIGRlY2lkZSB0byBzdG9wIHRoZSBzdHVkeSB0cmVhdG1lbnQsIHlvdSB3aWxsIGhhdmUgMiBtb3JlIHZpc2l0cyBhbmQgd2lsbCBoYXZlIHBob25lIGNhbGxzIHdpdGggdGhlIHN0dWR5IHRlYW0gZXZlcnkgMyBtb250aHMuPC9oNj48YnI+PGJyPjwvZGl2PiJd[\/vc_raw_html][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;152286&#8243;]<span class='tooltipsall tooltip_post_id_112288 classtoolTips112288'>Follow-up<\/span>[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112255&#8243; back_repeat=&#8221;no-repeat&#8221; back_attachment=&#8221;scroll&#8221; back_position=&#8221;center center&#8221; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_flip=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-140002","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/stg.strategist3trial.com\/en-au\/wp-json\/wp\/v2\/pages\/140002","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stg.strategist3trial.com\/en-au\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/stg.strategist3trial.com\/en-au\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/stg.strategist3trial.com\/en-au\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/stg.strategist3trial.com\/en-au\/wp-json\/wp\/v2\/comments?post=140002"}],"version-history":[{"count":0,"href":"https:\/\/stg.strategist3trial.com\/en-au\/wp-json\/wp\/v2\/pages\/140002\/revisions"}],"wp:attachment":[{"href":"https:\/\/stg.strategist3trial.com\/en-au\/wp-json\/wp\/v2\/media?parent=140002"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}